140 related articles for article (PubMed ID: 34817735)
1. ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer.
Wang S; Zhang H; Liu H; Guo X; Ma R; Zhu W; Gao P
Med Oncol; 2021 Nov; 39(1):15. PubMed ID: 34817735
[TBL] [Abstract][Full Text] [Related]
2. ELK1/KIFC1 axis promotes breast cancer cell proliferation by regulating glutathione metabolism.
Yang B; Wang H; Xiao J; Chen W; Chen W
J Obstet Gynaecol Res; 2023 Aug; 49(8):2175-2184. PubMed ID: 37339943
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
[TBL] [Abstract][Full Text] [Related]
4. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
Lv P; Xue Y
Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
[TBL] [Abstract][Full Text] [Related]
5. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
[TBL] [Abstract][Full Text] [Related]
6. KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer.
Teng Y; Guo B; Mu X; Liu S
Biomed Pharmacother; 2018 Dec; 108():766-773. PubMed ID: 30248545
[TBL] [Abstract][Full Text] [Related]
7. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
8. NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.
Köenig A; Linhart T; Schlengemann K; Reutlinger K; Wegele J; Adler G; Singh G; Hofmann L; Kunsch S; Büch T; Schäfer E; Gress TM; Fernandez-Zapico ME; Ellenrieder V
Gastroenterology; 2010 Mar; 138(3):1189-99.e1-2. PubMed ID: 19900447
[TBL] [Abstract][Full Text] [Related]
9. High expression of KIF26B in breast cancer associates with poor prognosis.
Wang Q; Zhao ZB; Wang G; Hui Z; Wang MH; Pan JF; Zheng H
PLoS One; 2013; 8(4):e61640. PubMed ID: 23585914
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
Ahmad A; Zhang W; Wu M; Tan S; Zhu T
Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
[TBL] [Abstract][Full Text] [Related]
11. Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).
Wei M; Liu B; Gu Q; Su L; Yu Y; Zhu Z
Cell Oncol (Dordr); 2013 Feb; 36(1):79-93. PubMed ID: 23184467
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion.
Gu S; Liang H; Qi D; Mao L; Mao G; Qian L; Zhang S
Onco Targets Ther; 2018; 11():3195-3203. PubMed ID: 29881293
[TBL] [Abstract][Full Text] [Related]
13. GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.
Wei S; Yu Z; Shi R; An L; Zhang Q; Zhang Q; Zhang T; Zhang J; Wang H
BMC Cancer; 2022 Aug; 22(1):881. PubMed ID: 35962333
[TBL] [Abstract][Full Text] [Related]
14. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
15. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer.
El Din GS; Youness RA; Assal RA; Gad MZ
Microrna; 2020; 9(5):346-353. PubMed ID: 33297930
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer.
Chen Q; Fu Y; Liu X; Wang P; Dai S; Zhu F; Liu T; Xu W; Wu J
Mol Carcinog; 2023 Dec; 62(12):1947-1959. PubMed ID: 37642304
[TBL] [Abstract][Full Text] [Related]
17. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
18. β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.
Xu J; Chen Y; Huo D; Khramtsov A; Khramtsova G; Zhang C; Goss KH; Olopade OI
Mol Carcinog; 2016 May; 55(5):431-9. PubMed ID: 25663530
[TBL] [Abstract][Full Text] [Related]
19. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
20. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
